论文信息 - Tumor Regression and Curability of Preclinical Neuroblastoma Models by PEGylated SN38 (EZN-2208), a Novel Topoisomerase I Inhibitor - 字舞流文

Tumor Regression and Curability of Preclinical Neuroblastoma Models by PEGylated SN38 (EZN-2208), a Novel Topoisomerase I Inhibitor

D. Ribatti | M. Cilli | L. Greenberger | F. Pastorino | M. Ponzoni | I. Horak | P. Sapra | L. Emionite | M. Loi | P. Becherini | Pastorino | nico Ribatti | Domenico Ribatti | Pastorino | nico Ribatti | Domenico Ribatti